The CEO of the company whose insurance leader was killed in New York pledged to help fix the health care industry while also ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...
The Baltimore City Board of School Commissioners is suing Eli Lilly and Co., UnitedHealth Group, CVS and several other drug ...
January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...
The job cuts reflect the normal maturation of companies such as Alameda-based Scribe, which is moving from a preclinical to ...
A private business has helped supercharge a controversial federal drug program. Patients and insurers have been left with big ...
Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs ...
CVS Caremark, OptumRx and St. Louis-based Express Scripts — are part of huge health conglomerates that also own insurers, ...
The laboratory of the latest Nobel Prize winner in Chemistry David Baker, headed by researcher Susana Vázquez, talks about ‘democratizing’ the discovery of therapies ...